LIPO-INJECTION W/METHYL B12 1 MG/ML W/PRES recalled over sterility concerns
- Recall date
- May 13, 2016
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Medaus, Inc. recalls LIPO-INJECTION W/METHYL B12 1 MG/ML W/PRES. (BENZYL ETOH 2%) ASCORBIC ACID-50MG, B1-50MG, B2-5 PHOS-5MG, B-3-50MG, B5-5…
- Recall number
- D-1206-2016
- FDA classification
- Class II
- Brand / firm
- Medaus, Inc.
- Sold / distributed
- U.S. Nationwide, Japan, and New Zealand.
Why it was recalled
Lack of Assurance of Sterility
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
LIPO-INJECTION W/METHYL B12 1 MG/ML W/PRES. (BENZYL ETOH 2%) ASCORBIC ACID-50MG, B1-50MG, B2-5 PHOS-5MG, B-3-50MG, B5-5MG, B6-5MG, METHYL B12-1MG, LIDOCAINE-10MG, METHIONINE 12.5 MG, INOSITOL 25MG, CHOLINE CHL 25MG/ML, In a) 5ML Vials and b) 10ML Vials, MEDAUS PHARMACY
Get recall alerts
Free email alert whenever Medaus, Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Medaus, Inc.